Answers

Short answer: Partly. Since 2020 the U.S. has shored up several core capabilities, but uneven state readiness, workforce/funding instability, eroding public trust, and weaker global coordination leave meaningful gaps. Overall preparedness is mixed. What’s stronger now - Medical countermeasures and stockpiles: The Strategic National Stockpile reports 158,000 ventilators on hand (about 10× pre‑COVI

Short answer: The U.S. is better prepared than it was in early 2020, but readiness is uneven and more fragile than it should be. Where the U.S. is stronger now - Federal response machinery exists and has matured. HHS’s ASPR is now a full operating division with BARDA, the Strategic National Stockpile, emergency operations, and supply‑chain programs it can mobilize for health crises. ASPR has a mu

Short answer: Better than in 2020 in several concrete ways, but still not where it needs to be—especially on workforce, coordination, stable funding, and global cooperation. Where the U.S. is stronger now - Faster medical countermeasures: HHS’s ASPR and BARDA have updated multi‑year plans and budgets to speed vaccines, drugs, diagnostics, and domestic manufacturing; FDA continues to refine emerge

Short answer: Partly. The U.S. has shored up some core capacities since 2020, but significant gaps and several 2025–2026 policy and funding shifts leave the country unevenly prepared for a fast‑moving pandemic. What’s stronger now - Medical countermeasures planning and stockpiles: HHS/ASPR published a 2025–2029 multiyear plan for vaccines, drugs, and diagnostics; the National Pre‑pandemic Influen

Short answer: Better than in 2019, but still not “ready.” The U.S. has stronger countermeasure, stockpile, and data capacities than before COVID-19, yet experts still flag chronic weaknesses in funding, workforce, data interoperability, supply chains, and federal–state coordination. What’s better now - Clearer federal architecture: HHS’s emergency arm (ASPR) was elevated to an operating division

Short answer: Partly. The U.S. is better positioned than it was in 2019, but GAO and other independent reviews still flag gaps—especially in coordination, data, workforce, legal authorities, and supply chains—that would hinder a fast, severe pandemic response. What’s stronger now - Faster countermeasures pipeline and planning: HHS’s medical countermeasure enterprise (BARDA/ASPR, CDC, NIH, FDA, Do